Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the U.S.

Elon Musk's Neuralink recently received approval from the US Food and Drug Administration (FDA) to trial Blindsight, its ...

Neurotech company Synchron has been making massive strides over the past couple of years. It's just announced that a trial ...

Blindsight, the experimental vision-restoring implant by Elon Musk’s brain-chip startup, Neuralink, has received the U.S.

Neuralink's blindsight device has received FDA Breakthrough Device designation and the company claims it can restore vision ...

The Blindsight device from Neuralink will enable even those who have lost both eyes and their optic nerve to see. Provided ...

The device is a variant of Neuralink's brain implant technology, in this case designed to "enable even those who have lost both eyes" to see, according to owner Elon Musk. Separately, progress is ...

Neuralink confirmed the FDA approval and stated that Blindsight has been awarded the Breakthrough Device Designation.

In early 2024, Neuralink performed its first human trial on a patient with paraplegia. Early results were promising; the patient was able to control a computer mouse with only his mind.

Elon Musk’s brain-chip startup, Neuralink, has achieved a significant milestone with its experimental implant, Blindsight, ...

This summary covers significant updates in the health sector, including US Senator Bernie Sanders' push for cheaper generic ...

ELON Musk’s brain-chip startup Neuralink said on Tuesday (Sep 17) that its experimental implant aimed at restoring vision ...